Abstract
We thank Xia et al. for raising some interesting points. Firstly, we recognize the peculiarity of rectal tumors, and therefore an exploratory analysis differentiating rectal vs descending or sigmoid colon was conducted and is available in the Supplementary Materials. Secondly, an increasing number of prognostic variables in metastatic colorectal cancer (CRC) has been identified in the last years, but many of them were not collected in clinical studies conducted a decade ago. All available data with a possible prognostic implication were included in the multivariable model to estimate the independent role of tumor location. Thirdly, the relative impact of the addition of bevacizumab was estimated through an adjusted interaction test between tumor location and treatment effect.

This publication has 12 references indexed in Scilit: